CTRI/2020/01/022935已完成未知
CLINICAL EVALUATION OF THE EFFICACY OF SOUBHAGYA SHUNTHI PAKA AND DASAMOOLARISTA IN SUTIKA PARICHARYA (POST NATAL CARE) - SPDA IN PNC
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Primipara / Multipara with non-complicated full term vaginal delivery,
- •2. Age between 20 ââ?¬â?? 35 years
- •3. Woman willing and able to participate in the study.
- •4. Woman in 3rdto 10thpostnatal day.
排除标准
- •1. Woman who delivered by Caesarian section or forceps delivery/ vacuum application
- •2. Woman after 11thpostnatal day.
- •3. Puerperium associated with complications like severe postpartum haemorrhage, acute inversion of uterus, puerperal eclampsia, psychosis, postnatal gestational Diabetes
- •4. With uncontrolled hypertension ( >160/100 mm of Hg).
- •5. With uncontrolled diabetes mellitus {HbA1c > 8.0 %.)
- •6. With evidence of malignancy.
- •6. Mothers with active herpes breast/breast abscess/retracted nipple/severely cracked nipples, having h/o of HbsAg+ve, HIV+ve, Tuberculosis, Chronic medical conditions.
- •7. Any other condition which the Principal Investigator thinks may jeopardize the study.
研究者
相似试验
尚未招募
2 期
TO STUDY THE EFFECT OF SAUBHAGYA SHUNTHI MODAK IN PREVENTION OF DISEASES AFTER DELIEVERYCTRI/2021/12/038807DR SHILPI SINGH
尚未招募
3 期
Effect Of Soubhagya Shunthi Leha In Sutika Makkala(Puerperal Pain)CTRI/2023/10/058253Dr Reeta C Vajramatti
尚未招募
2 期
MANAGEMENT OF NADIVRANA WITH SPECIAL REFERENCE TO PILONIDAL SINUS BY TWO TYPES OF VARTIS.CTRI/2022/08/044894Dr Prasadshakti G Gannur
尚未招募
2 期
Role of Snuhiadi Varti and Apamarg kshar sutra in treatment of Fistula in anoCTRI/2024/02/062252Shri Krishna Govt. Ayurvedic College and Hospital, Kurukshetra, Haryana
进行中（未招募）
1 期
Evaluation of the efficacy and safety of sugammadex (Bridion) in children with renal failure. - sugammadex in children with renal failureSugammadex is a selective relaxant binding agent, which is administered in case of a rocuronium-induced neuromuscular block, during general anaesthesia. The aim of the trial is to investigate the use, efficacy and safety of sugammadex in children (2-17 years) with moderate to severe renal failure (creatinine clearance < 30 ml/min), compared to children with normal renal function.MedDRA version: 9.1Level: HLTClassification code 10038443Term: Renal failure and impairmentMedDRA version: 9.1Level: LLTClassification code 10009119Term: Chronic renal failureMedDRA version: 9.1Level: LLTClassification code 10014647Term: End stage renal failureEUCTR2008-008246-20-NLRadboud University Nijmegen Medical Center, Department of Anaesthesiology, Pain and Palliative Medic20